THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
Frederic Dietrich, Managing Director
Leveraging over three decades of experience and industry-leading pharma manufacturing capabilities, Dec Group is ideally positioned to help clients achieve end-to-end drug production in their in-house facilities. The organization acts as a global player offering turnkey solutions and consultancy encompassing molecule handling to the final product packaging process, aiming to uplift productivity, quality, and worker safety.
“We are not an equipment supplier. We provide solutions that enable modular and continuous manufacturing,” says Frederic Dietrich, Managing Director of Dec Group. This helps clients reduce facility footprint by 50 to 60 percent while facilitating flexibility in production volumes and saving costs.
Dec Group initiated operations by introducing an innovative concept for the safe conveying of powder. It developed the powder transfer system (PTS), which redefined powder handling, significantly enhancing containment and process efficiency during the transfer of bulk materials within pharmaceutical manufacturing. This garnered it global acclamation. Since then, as a part of the journey to becoming a comprehensive solutions provider, it acquired Jetpharma for process isolators and micronizing technology, Inno4Life for aseptic fill/finish, ExtractTechnology for isolators and contained solutions, and Alconbury Weston for continuous manufacturing, notably flow chemistry solutions.
Its solutions have five primary product divisions that work as a single entity. PTS facilitates enclosed powder handling, mimicking liquid-like safe transfers across manufacturing stages. Its milling technology helps achieve even sub-micron particle sizes, which is vital for superior inhalable drug production. The filling technology is for the aseptic filling of products in vials, syringes, or special packaging and extends to advanced applications like cell and gene therapy and microdosing. The isolator technology handles efficient repackaging of APIs and other materials, while the continuous manufacturing system connects the dots to ensure reduced production downtime and cost-effective manufacturing.
For superior blending of powders, the company deploys a one-of-a-kind first-order mixing technology dubbed PTS Batchmixer®. Traditional technologies use rotating mixers or agitation tools to blend powders, which degrades product quality. Dec Group’s closed, cleanable, and serviceable mixer has no moving parts and uses circulation to perform the task.
Addressing its aim to uplift productivity, quality, and operator protection, Dec Group considers certain core values during solution design. It reduces the chances of potential explosions while charging the powders into reactors containing solvents, maintaining superior safety parameters in the systems. The isolators handle the containment of highly potent and toxic APIs while eliminating hygiene issues like cross-contamination of the powders. When transferring powder across equipment and filling them into tablets and capsules, its closed path PTS technology ensures zero particle damage, no change of powder characteristics, and guarantees a GMP/sterile condition during the packaging of the powder, uplifting drug integrity.
We are not an equipment supplier. We provide solutions that enable modular and continuous manufacturing
Dec Group’s offerings become a repeated choice for customers because of its comprehensive solutions, which prevent them from approaching multiple vendors for different technologies, reducing cost and lead times. This also benefits them from a compliance standpoint, as the company designs its solutions adhering to the regulatory requirements. If any client wants third-party equipment, it is able to provide that through its collaboration with leading equipment providers.
Dec Group shines as a symbol of comprehensive technological excellence in pharmaceutical manufacturing. Uplifting productivity, quality, and safety of clients’ operations, along with enabling semi and fully continuous manufacturing, it helps clients achieve profitability and competitive advantage in the ever-evolving pharma world.
Company
Dec Group
Management
Frederic Dietrich, Managing Director
Description
Dec Group leverages over three decades of experience and industry-leading capabilities to facilitate end-to-end drug production through modular and continuous manufacturing. It aims to uplift productivity, quality, and worker safety for clients and offers turnkey solutions and consultancy encompassing molecule handling to the final product packaging process.
ECUBLENS - Dec Group, a leading provider of materials handling and process solutions, has announced a strategic partnership with IKA, a renowned technology-driven solutions leader. This collaboration aims to revolutionize the battery manufacturing sector by providing comprehensive solutions for conveying and bulk handling, blending/dispersion, drying, mixing, milling, and packaging battery powders.
As the demand for batteries continues to rise, optimizing the manufacturing process has become increasingly crucial.
Through this partnership with IKA, Dec Group is well-positioned to deliver cutting-edge solutions to customers, addressing the challenges in battery production. Leveraging their combined industry expertise, the collaboration aims to position them at the forefront of battery manufacturing solutions and enhance their ability to meet the evolving market needs.
One key application focuses on battery powder handling, a critical phase demanding precise control and accuracy for ensuring the quality and consistency of battery components. Dec Group, with advanced powder handling and processing systems, can streamline this process, minimizing waste and maximizing efficiency.
Additionally, the collaboration with IKA will significantly enhance the electrode slurry manufacturing process. The electrode slurry, a vital component in battery manufacturing, requires meticulous attention to detail. This process plays a crucial role in determining the quality of electrodes, impacting the overall performance of lithium-ion batteries. The electrode slurry consists of a mixture of active materials like NMC or LFP for the cathode, graphite for the anode, along with conductive additives, binders, and solvents.
This partnership underscores Dec Group's commitment to staying at the forefront of technological advancements, providing customers with state-of-the-art solutions. By offering advanced process solutions, the partnership aims to empower customers to meet the growing demand for batteries across various industries, delivering high-quality products with reduced production times.